Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching-Reference-Cited by-同舟云学术

Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching

Published:2003-09 Issue:18 Volume:13 Page:2967-2971
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Furet Pascal,Bold Guido,Hofmann Francesco,Manley Paul,Meyer Thomas,Altmann Karl-Heinz

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. Tumor angiogenesis as a therapeutic target

2. Tumor angiogenesis: past, present and the near future

3. Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors

4. Manley, P. W.; Furet, P. In Anticancer Agents: Frontiers in Cancer Chemotherapy; Ojima, I., Vite, G., Altmann, K., Eds.; ACS Symposium Series 796; American Chemical Society: Washington, DC, 2001; p 282.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform;Bioorganic Chemistry;2024-05

2. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure–activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study;Bioorganic Chemistry;2021-05

3. Thionation of Aminophthalimide Hindered Carbonyl Groups and Application to the Synthesis of 3,6′-Dithionated Pomalidomides;Synlett;2021-04-28

4. Synthesis and evaluation of novel radioiodinated anthranilate derivatives for in vivo imaging of vascular endothelial growth factor receptor with single-photon emission computed tomography;Annals of Nuclear Medicine;2020-05-08

5. Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors;Bioorganic & Medicinal Chemistry;2020-03